Summary of Purpose
Major adverse cardiovascular events (MACE) are a leading cause of serious complications and death following major noncardiac surgery. The heart biomarkers brain-type natriuretic peptide (BNP) and high-sensitivity troponin I/T (hs-TnI/T), may aid in estimating the risk of surgery - low values may permit identifying patients at a very low risk of postoperative complications, potentially helping to avoid unnecessary...Read More →
The following dates are available for this trial. Trial information last updated on 2 February 2018.
|1 Sep 2015||24 Aug 2015||1 Mar 2019||1 Feb 2020||1 Feb 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Conditions See All
- Allocation: Randomized
- Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
- Purpose: Treatment
- Endpoint: Safety/Efficacy Study
- Intervention: Parallel Assignment
- Miodrag Filipovic, Prof. Dr.